Trials / Completed
CompletedNCT03288038
The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 382 (actual)
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients with Primary Hypercholesterolemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin | |
| DRUG | Ezetimibe |
Timeline
- Start date
- 2014-10-13
- Primary completion
- 2015-11-19
- Completion
- 2015-11-19
- First posted
- 2017-09-19
- Last updated
- 2017-09-19
Locations
20 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03288038. Inclusion in this directory is not an endorsement.